Home › Companies › BICYCLE THERAPEUTICS PLC › 2024-2025

BICYCLE THERAPEUTICS PLC 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and BICYCLE THERAPEUTICS PLC’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

9Reported items
108Asset managers
359Fund votes
June 17, 2025Meeting date

Results at a glance

Meeting of June 17, 2025: 9 items on BICYCLE THERAPEUTICS PLC’s Form 8-K, filed June 17, 2025: 9 without a stated outcome.

Material dissent

9. To approve an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth in the Company's… 78% of votes cast Outcome not stated Under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025

Explore BICYCLE THERAPEUTICS PLC in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by BICYCLE THERAPEUTICS PLC

These tallies are BICYCLE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BICYCLE THERAPEUTICS PLC — official shareholder meeting results, meeting held June 17, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
1. To re-elect as a director Alessandro Riva	40,034,345	9,086,349	14,365	--	--	82%	Not verified	—
2. To re-elect as a director Stephen Sands	47,652,747	1,481,237	1,075	--	--	97%	Not verified	—
3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement	47,287,428	1,743,008	104,623	--	--	96%	Not verified	—
4. To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S	49,093,195	41,363	501	--	--	99.9%	Not verified	—
5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K	49,094,477	40,022	560	--	--	99.9%	Not verified	—
6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K	49,116,858	17,701	500	--	--	99.9%	Not verified	—
7. To receive and adopt the Company's U.K	49,001,464	133,090	505	--	--	99.7%	Not verified	—
8. To approve the directors' remuneration report for the year ended December 31, 2024, which report is set forth in the Company's definitive proxy statement	47,393,255	1,733,604	8,200	--	--	96%	Not verified	—
9. To approve an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth in the Company's definitive proxy statement	38,137,068	10,979,123	18,868	--	--	78%	Not verified	—

Source: BICYCLE THERAPEUTICS PLC, Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.

How asset managers voted at the BICYCLE THERAPEUTICS PLC 2024-2025 meeting

Each item below shows how the 108 asset managers that disclosed a BICYCLE THERAPEUTICS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BICYCLE THERAPEUTICS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. 1. To re-elect as a director Alessandro Riva

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST

FOR: 40,034,345AGAINST: 9,086,349

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To re-elect Alessandro Riva as a director, who retires in accordance with the Articles of Association.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“1. To re-elect as a director Alessandro Riva”): 40,034,345 for, 9,086,349 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 1,509,646 for, 1,650,404 against.

FORAGAINST

FOR: 1,509,646AGAINST: 1,650,404

Largest asset managers voting on “To re-elect Alessandro Riva as a director, who retires in accordance with the Articles of Association.” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Against	Vote
T. Rowe Price	1,231,314	0	For
HARBOR FUNDS	0	1,000,820	Against
Principal	0	293,300	Against
Harbor Funds II	149,250	0	For
BlackRock	91,153	53,054	Mixed
Goldman Sachs	0	100,250	Against
Morgan Stanley	0	58,724	Against
State Street	1,268	30,155	Against
John Hancock	25,602	0	For
OLD WESTBURY FUNDS INC	0	25,352	Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	0	21,900	Against
Harbor ETF Trust	0	16,482	Against
Listed Funds Trust	0	14,396	Against
ETF Series Solutions	0	12,764	Against
STEWARD FUNDS, INC.	0	11,209	Against
Equitable	11,014	0	For
Mercer Funds	0	5,511	Against
ETFis Series Trust I	0	4,131	Against
ProShares	0	1,779	Against
Blackstone Alternative Investment Funds	0	300	Against
Fidelity	0	277	Against
CITY NATIONAL ROCHDALE FUNDS	45	0	For

2. 2. To re-elect as a director Stephen Sands

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 47,652,747AGAINST: 1,481,237

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To re-elect Stephen Sands as a director, who retires in accordance with the Articles of Association.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“2. To re-elect as a director Stephen Sands”): 47,652,747 for, 1,481,237 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 3,067,629 for, 92,421 against.

FOR

FOR: 3,067,629AGAINST: 92,421

Largest asset managers voting on “To re-elect Stephen Sands as a director, who retires in accordance with the Articles of Association.” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Against	Vote
T. Rowe Price	1,231,314	0	For
HARBOR FUNDS	1,000,820	0	For
Principal	293,300	0	For
Harbor Funds II	149,250	0	For
BlackRock	53,054	91,153	Mixed
Goldman Sachs	100,250	0	For
Morgan Stanley	58,724	0	For
State Street	30,155	1,268	For
John Hancock	25,602	0	For
OLD WESTBURY FUNDS INC	25,352	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	0	For
Harbor ETF Trust	16,482	0	For
Listed Funds Trust	14,396	0	For
ETF Series Solutions	12,764	0	For
STEWARD FUNDS, INC.	11,209	0	For
Equitable	11,014	0	For
Mercer Funds	5,511	0	For
ETFis Series Trust I	4,131	0	For
ProShares	1,779	0	For
Blackstone Alternative Investment Funds	300	0	For
Fidelity	277	0	For
CITY NATIONAL ROCHDALE FUNDS	45	0	For

3. 7. To receive and adopt the Company's U.K

Outcome not verifiedCORPORATE GOVERNANCEReported outcome: Not verified

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 49,001,464AGAINST: 133,090

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. Annual Report").

BICYCLE THERAPEUTICS PLC’s own tally for this item (“7. To receive and adopt the Company's U.K”): 49,001,464 for, 133,090 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 3,160,050 for.

FOR

FOR: 3,160,050

Largest asset managers voting on “To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the ” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
T. Rowe Price	1,231,314	For
HARBOR FUNDS	1,000,820	For
Principal	293,300	For
Harbor Funds II	149,250	For
BlackRock	144,207	For
Goldman Sachs	100,250	For
Morgan Stanley	58,724	For
State Street	31,423	For
John Hancock	25,602	For
OLD WESTBURY FUNDS INC	25,352	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	For
Harbor ETF Trust	16,482	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,764	For
STEWARD FUNDS, INC.	11,209	For
Equitable	11,014	For
Mercer Funds	5,511	For
ETFis Series Trust I	4,131	For
ProShares	1,779	For
Blackstone Alternative Investment Funds	300	For
Fidelity	277	For
CITY NATIONAL ROCHDALE FUNDS	45	For

4. 9. To approve an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan, which amendment is set…

Outcome not verifiedCOMPENSATIONReported outcome: Not verified

78% Majority: yes · of votes cast

FOR 78%AGAINST

FOR: 38,137,068AGAINST: 10,979,123

Details: description as filed, official tally, votes by 23 asset managers

Description as filed by funds: To approve an amendment to our Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth as Annex C to the proxy statement.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“9. To approve an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth in the Company's definitive proxy statement”): 38,137,068 for, 10,979,123 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 23 asset managers below reported 149,250 for, 3,010,946 against.

AGAINST

FOR: 149,250AGAINST: 3,010,946

Largest asset managers voting on “To approve an amendment to our Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth a” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Against	Vote
T. Rowe Price	0	1,231,314	Against
HARBOR FUNDS	0	1,000,820	Against
Principal	0	293,300	Against
Harbor Funds II	149,250	0	For
BlackRock	0	144,207	Against
Goldman Sachs	0	100,250	Against
Morgan Stanley	0	58,724	Against
State Street	0	31,423	Against
John Hancock	0	25,602	Against
OLD WESTBURY FUNDS INC	0	25,352	Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	0	21,900	Against
Harbor ETF Trust	0	16,482	Against
Listed Funds Trust	0	14,396	Against
ETF Series Solutions	0	12,764	Against
STEWARD FUNDS, INC.	0	11,209	Against
Equitable	0	11,014	Against
Mercer Funds	0	5,511	Against
ETFis Series Trust I	0	4,131	Against
ProShares	0	1,779	Against
Blackstone Alternative Investment Funds	0	300	Against
Fidelity	0	277	Against
UNITED CAPITAL FINANCIAL ADVISORS, LLC	0	146	Against
CITY NATIONAL ROCHDALE FUNDS	0	45	Against

5. 3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the…

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 8 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 47,287,428AGAINST: 1,743,008

Details: description as filed, official tally, votes by 106 asset managers

Description as filed by funds: TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement”): 47,287,428 for, 1,743,008 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 22 asset managers voting on “TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STA” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
T. Rowe Price	1,231,314	For
HARBOR FUNDS	1,000,820	For
Principal	293,300	For
Harbor Funds II	149,250	For
BlackRock	144,207	For
Goldman Sachs	100,250	For
Morgan Stanley	58,724	For
State Street	31,423	For
John Hancock	25,602	For
OLD WESTBURY FUNDS INC	25,352	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	For
Harbor ETF Trust	16,482	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,764	For
STEWARD FUNDS, INC.	11,209	For
Equitable	11,014	For
Mercer Funds	5,511	For
ETFis Series Trust I	4,131	For
ProShares	1,779	For
Blackstone Alternative Investment Funds	300	For
Fidelity	277	For
CITY NATIONAL ROCHDALE FUNDS	45	For

Fund voting reports, all 22 managers: 3,160,050 for.

Institutional-manager reports: 89 asset managers voting on “TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STA” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Against	Vote
BAKER BROS. ADVISORS LP	10,885,357	0	For
FCPM III SERVICES B.V.	3,452,330	0	For
Point72	3,296,624	0	For
ARMISTICE CAPITAL, LLC	2,162,468	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	2,113,223	0	For
Siren, L.L.C.	1,552,106	0	For
T. Rowe Price	1,528,984	0	For
BNP Paribas Asset Management Holding S.A.	0	1,054,752	Against
EcoR1 Capital, LLC	910,000	0	For
AXA INVESTMENT MANAGERS UK Ltd	0	553,682	Against
Deep Track Capital, LP	485,355	0	For
PRINCIPAL GLOBAL INVESTORS	408,296	0	For
Woodline Partners LP	362,325	0	For
COMERICA BANK	306,779	0	For
PLATINUM INVESTMENT MANAGEMENT LTD	287,599	0	For
SILVERCREST ASSET MANAGEMENT GROUP LLC	134,059	0	For
Renaissance	121,660	0	For
PINNACLE ASSOCIATES LTD	106,155	0	For
Janney Montgomery Scott LLC	105,978	0	For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	83,741	0	For
DAFNA Capital Management LLC	80,799	0	For
Allianz	73,100	0	For
Citadel	66,459	0	For
BESSEMER INVESTMENT MANAGEMENT LLC	50,704	0	For
Bessemer Trust Co of California, N.A.	50,704	0	For

Institutional-manager reports, all 89 managers: 28,868,419 for, 1,609,154 against. Showing the 25 largest; see all in the interactive database.

6. 8. To approve the directors' remuneration report for the year ended December 31, 2024, which report is set forth in the…

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 47,393,255AGAINST: 1,733,604

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 (THE "DIRECTORS' REMUNERATION REPORT"), WHICH IS SET FORTH AS ANNEX A TO THE PROXY STATEMENT.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“8. To approve the directors' remuneration report for the year ended December 31, 2024, which report is set forth in the Company's definitive proxy statement”): 47,393,255 for, 1,733,604 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Fund voting reports: 22 asset managers voting on “TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 (THE "DIRECTORS' REMUNERATI” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
T. Rowe Price	1,231,314	For
HARBOR FUNDS	1,000,820	For
Principal	293,300	For
Harbor Funds II	149,250	For
BlackRock	144,207	For
Goldman Sachs	100,250	For
Morgan Stanley	58,724	For
State Street	31,423	For
John Hancock	25,602	For
OLD WESTBURY FUNDS INC	25,352	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	For
Harbor ETF Trust	16,482	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,764	For
STEWARD FUNDS, INC.	11,209	For
Equitable	11,014	For
Mercer Funds	5,511	For
ETFis Series Trust I	4,131	For
ProShares	1,779	For
Blackstone Alternative Investment Funds	300	For
Fidelity	277	For
CITY NATIONAL ROCHDALE FUNDS	45	For

Fund voting reports, all 22 managers: 3,160,050 for.

Institutional-manager reports: 10 asset managers voting on “TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 (THE "DIRECTORS' REMUNERATI” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
Siren, L.L.C.	1,552,106	For
Palo Alto Investors LP	248,934	For
WOODSTOCK CORP	24,981	For
BlackRock	22,806	For
Argent Trust Co	1,690	For
ADVISOR PARTNERS II, LLC	1,173	For
Granahan Investment Management, LLC	404	For
HANCOCK WHITNEY CORP	200	For
Sonora Investment Management Group, LLC	100	For
Chicago Partners Investment Group LLC	22	For

Institutional-manager reports, all 10 managers: 1,852,416 for.

7. 6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K

Outcome not verifiedAUDIT-RELATEDCOMPENSATIONReported outcome: Not verified

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 49,116,858AGAINST: 17,701

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2025.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K”): 49,116,858 for, 17,701 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 3,160,050 for.

FOR

FOR: 3,160,050

Largest asset managers voting on “To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending De” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
T. Rowe Price	1,231,314	For
HARBOR FUNDS	1,000,820	For
Principal	293,300	For
Harbor Funds II	149,250	For
BlackRock	144,207	For
Goldman Sachs	100,250	For
Morgan Stanley	58,724	For
State Street	31,423	For
John Hancock	25,602	For
OLD WESTBURY FUNDS INC	25,352	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	For
Harbor ETF Trust	16,482	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,764	For
STEWARD FUNDS, INC.	11,209	For
Equitable	11,014	For
Mercer Funds	5,511	For
ETFis Series Trust I	4,131	For
ProShares	1,779	For
Blackstone Alternative Investment Funds	300	For
Fidelity	277	For
CITY NATIONAL ROCHDALE FUNDS	45	For

8. To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of…

No official matchAUDIT-RELATED

100% of fund votes cast · no official result

FOR

Details: description as filed, votes by 22 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025.

The 22 asset managers below reported 3,160,050 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 3,160,050

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the l” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
T. Rowe Price	1,231,314	For
HARBOR FUNDS	1,000,820	For
Principal	293,300	For
Harbor Funds II	149,250	For
BlackRock	144,207	For
Goldman Sachs	100,250	For
Morgan Stanley	58,724	For
State Street	31,423	For
John Hancock	25,602	For
OLD WESTBURY FUNDS INC	25,352	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	For
Harbor ETF Trust	16,482	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,764	For
STEWARD FUNDS, INC.	11,209	For
Equitable	11,014	For
Mercer Funds	5,511	For
ETFis Series Trust I	4,131	For
ProShares	1,779	For
Blackstone Alternative Investment Funds	300	For
Fidelity	277	For
CITY NATIONAL ROCHDALE FUNDS	45	For

9. 5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 49,094,477AGAINST: 40,022

Details: description as filed, official tally, votes by 22 asset managers

Description as filed by funds: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.

BICYCLE THERAPEUTICS PLC’s own tally for this item (“5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K”): 49,094,477 for, 40,022 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 22 asset managers below reported 3,160,050 for.

FOR

FOR: 3,160,050

Largest asset managers voting on “To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England,” at BICYCLE THERAPEUTICS PLC, 2024-2025
Asset manager	For	Vote
T. Rowe Price	1,231,314	For
HARBOR FUNDS	1,000,820	For
Principal	293,300	For
Harbor Funds II	149,250	For
BlackRock	144,207	For
Goldman Sachs	100,250	For
Morgan Stanley	58,724	For
State Street	31,423	For
John Hancock	25,602	For
OLD WESTBURY FUNDS INC	25,352	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	21,900	For
Harbor ETF Trust	16,482	For
Listed Funds Trust	14,396	For
ETF Series Solutions	12,764	For
STEWARD FUNDS, INC.	11,209	For
Equitable	11,014	For
Mercer Funds	5,511	For
ETFis Series Trust I	4,131	For
ProShares	1,779	For
Blackstone Alternative Investment Funds	300	For
Fidelity	277	For
CITY NATIONAL ROCHDALE FUNDS	45	For

Largest BICYCLE THERAPEUTICS PLC shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 69,202,355 shares outstanding at the time of that meeting.

Fund voting reports: top BICYCLE THERAPEUTICS PLC shareholders by shares voted on “TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED…”, 2024-2025
#	Asset manager	% of shares outstanding
1	T. Rowe Price	1.78%
2	HARBOR FUNDS	1.45%
3	Principal	0.42%
4	Harbor Funds II	0.22%
5	BlackRock	0.21%
6	Goldman Sachs	0.14%
7	Morgan Stanley	0.08%
8	State Street	0.05%
9	John Hancock	0.04%
10	OLD WESTBURY FUNDS INC	0.04%

Institutional-manager reports: top BICYCLE THERAPEUTICS PLC shareholders by shares voted on “TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED…”, 2024-2025
#	Asset manager	% of shares outstanding
1	BAKER BROS. ADVISORS LP	15.73%
2	FCPM III SERVICES B.V.	4.99%
3	Point72	4.76%
4	ARMISTICE CAPITAL, LLC	3.12%
5	WESTFIELD CAPITAL MANAGEMENT CO LP	3.05%
6	Siren, L.L.C.	2.24%
7	T. Rowe Price	2.21%
8	BNP Paribas Asset Management Holding S.A.	1.52%
9	EcoR1 Capital, LLC	1.31%
10	AXA INVESTMENT MANAGERS UK Ltd	0.80%

Reported BICYCLE THERAPEUTICS PLC holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

BICYCLE THERAPEUTICS PLC holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Point72	5.34%	13F
Armistice Capital, LLC	4.91%	13G
LONG FOCUS CAPITAL MANAGEMENT, LLC	4.78%	13G
Raymond Debbane	2.26%	13G
T. Rowe Price	2.22%	13F
Morgan Stanley	1.44%	13F
BlackRock	0.47%	13F
Renaissance Technologies	0.44%	13F
Citadel Advisors	0.24%	13F
State Street	0.12%	13F

Percentages above are of 69,202,355 shares outstanding, as reported by BICYCLE THERAPEUTICS PLC on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BICYCLE THERAPEUTICS PLC’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At BICYCLE THERAPEUTICS PLC's shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 108 asset managers reported how they voted in their SEC Form N-PX filings, covering 359 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BICYCLE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.

BICYCLE THERAPEUTICS PLC proxy season coverage: 2023-2024 · 2024-2025 (this page).

Download data (CSV): ballot items · votes by manager · column guide.